TANG Capital Partners L.P., 10% Owner, Officer, Chief Financial Officer at LA JOLLA PHARMACEUTICAL CO (LJPC), sold 875,983 shares at $3.66 ($3.4M) on 2021-12-01, disclosed to the SEC on 2021-12-01.
Open-market sale of $3.4M LJPC by 10% Owner, Officer, Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.10 | 193,403 | $793K | 23.0% |
| 2 | $4.10 | 193,403 | $793K | 23.0% |
| 3 | $3.95 | 6,597 | $26K | 0.8% |
| 4 | $3.95 | 63,745 | $252K | 7.3% |
| 5 | $3.95 | 63,745 | $252K | 7.3% |
| 6 | $3.66 | 41,290 |
| $151K |
| 4.4% |
| 7 | $3.66 | 41,290 | $151K | 4.4% |
| 8 | $3.76 | 136,255 | $512K | 14.9% |
| 9 | $3.76 | 136,255 | $512K | 14.9% |
| Total | $3.93 avg | 875,983 | $3.4M | 100% |
| Filing → |
| TCRR | BUY | 2023-05-10 | $275K | — | Filing → |
| TCRR | BUY | 2023-05-05 | $1.1M | — | Filing → |
| APVO | SELL | 2021-11-26 | $17.2M | — | Filing → |